{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:45:08Z","timestamp":1791409508768,"version":"4.3.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/leu.2011.152","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T08:50:17Z","timestamp":1308905417000},"page":"1768-1781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells"],"prefix":"10.1038","volume":"25","author":[{"given":"E","family":"Tibaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Brunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Frezzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gattazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zambello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gringeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"BFleu2011152_CR1","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","volume":"103","author":"FK Stevenson","year":"2004","unstructured":"Stevenson FK, Caligaris-Cappio F . Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004; 103: 4389\u20134395.","journal-title":"Blood"},{"key":"BFleu2011152_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804\u2013815.","journal-title":"N Engl J Med"},{"key":"BFleu2011152_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","volume":"18","author":"S Cuni","year":"2004","unstructured":"Cuni S, Perez-Aciego P, Perez-Chacon G, Vargas JA, Sanchez A, Martin-Saavedra FM et al. A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391\u20131400.","journal-title":"Leukemia"},{"key":"BFleu2011152_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","volume":"111","author":"PG Longo","year":"2008","unstructured":"Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG . The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008; 111: 846\u2013855.","journal-title":"Blood"},{"key":"BFleu2011152_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","volume":"101","author":"S Lanham","year":"2003","unstructured":"Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G . Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 2003; 101: 1087\u20131093.","journal-title":"Blood"},{"key":"BFleu2011152_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893\u2013901.","journal-title":"N Engl J Med"},{"key":"BFleu2011152_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1084\/jem.194.4.455","volume":"194","author":"M Kraus","year":"2001","unstructured":"Kraus M, Pao LI, Reichlin A, Hu Y, Canono B, Cambier JC et al. Interference with immunoglobulin (Ig)\u03b1 immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Ig\u03b2 cytoplasmic tail. J Exp Med 2001; 194: 455\u2013469.","journal-title":"J Exp Med"},{"key":"BFleu2011152_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0952-7915(02)00344-8","volume":"14","author":"T Kurosaki","year":"2002","unstructured":"Kurosaki T . Regulation of B cell fates by BCR signaling components. Curr Opin Immunol 2002; 14: 341\u2013347.","journal-title":"Curr Opin Immunol"},{"key":"BFleu2011152_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro H, Clark EA . Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002; 2: 945\u2013956.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2011152_CR10","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.155.7.3281","volume":"155","author":"JC Cambier","year":"1995","unstructured":"Cambier JC . Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 1995; 155: 3281\u20133285.","journal-title":"J Immunol"},{"key":"BFleu2011152_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1097-2765(02)00739-6","volume":"10","author":"V Rolli","year":"2002","unstructured":"Rolli V, Gallwitz M, Wossning T, Flemming A, Schamel WW, Z\u00fcrn C et al. Amplification of B cell antigen receptor signaling by a Syk\/ITAM positive feedback loop. Mol Cell 2002; 10: 1057\u20131069.","journal-title":"Mol Cell"},{"key":"BFleu2011152_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.4049\/jimmunol.165.4.1738","volume":"165","author":"A Hashimoto","year":"2000","unstructured":"Hashimoto A, Takeda K, Inaba M, Sekimata M, Kaisho T, Ikehara S et al. Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function. J Immunol 2000; 165: 1738\u20131742.","journal-title":"J Immunol"},{"key":"BFleu2011152_CR13","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/science.1071546","volume":"296","author":"SB Gauld","year":"2002","unstructured":"Gauld SB, Dal Porto JM, Cambier JC . B cell antigen receptor signaling: roles in cell development and disease. Science 2002; 296: 1641\u20131642.","journal-title":"Science"},{"key":"BFleu2011152_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/smim.1998.0122","volume":"10","author":"AL DeFranco","year":"1998","unstructured":"DeFranco AL, Chan VW, Lowell CA . Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin Immunol 1998; 10: 299\u2013307.","journal-title":"Semin Immunol"},{"key":"BFleu2011152_CR15","first-page":"9","volume":"22","author":"Y Xu","year":"2005","unstructured":"Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM . Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 2005; 22: 9\u201318.","journal-title":"Immunity"},{"key":"BFleu2011152_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1172\/JCI200522094","volume":"115","author":"A Contri","year":"2005","unstructured":"Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L et al. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 2005; 115: 369\u2013378.","journal-title":"J Clin Invest"},{"key":"BFleu2011152_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.346","volume":"23","author":"S Gobessi","year":"2009","unstructured":"Gobessi S, Laurenti L, Longo PG, Carsetti L, Berno V, Sica S et al. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia 2009; 23: 686\u2013697.","journal-title":"Leukemia"},{"key":"BFleu2011152_CR18","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1182\/blood-2002-02-0539","volume":"100","author":"I Ringshausen","year":"2002","unstructured":"Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C et al. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase C delta. Blood 2002; 100: 3741\u20133748.","journal-title":"Blood"},{"key":"BFleu2011152_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/10428190410001683642","volume":"45","author":"JM Plate","year":"2004","unstructured":"Plate JM . PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation. Leuk Lymphoma 2004; 45: 1519\u20131529.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011152_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/sj.leu.2404073","volume":"20","author":"A Sainz-Perez","year":"2006","unstructured":"Sainz-Perez A, Gary-Gouy H, Portier A, Davi F, Merle-Beral H, Galanaud P et al. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia 2006; 20: 498\u2013504.","journal-title":"Leukemia"},{"key":"BFleu2011152_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri1808","volume":"6","author":"JG Monroe","year":"2006","unstructured":"Monroe JG . ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 2006; 6: 283\u2013294.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2011152_CR22","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1182\/blood-2008-02-139139","volume":"112","author":"L Trentin","year":"2008","unstructured":"Trentin L, Frasson M, Donella-Deana A, Frezzato F, Pagano MA, Tibaldi E et al. Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. Blood 2008; 112: 4665\u20134674.","journal-title":"Blood"},{"key":"BFleu2011152_CR23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2007-11-123984","volume":"112","author":"A Veldurthy","year":"2008","unstructured":"Veldurthy A, Patz M, Hagist S, Pallasch CP, Wendtner CM, Hallek M et al. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. Blood 2008; 112: 1443\u20131452.","journal-title":"Blood"},{"key":"BFleu2011152_CR24","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","volume":"112","author":"DY Hallaert","year":"2008","unstructured":"Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E . c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Blood 2008; 112: 5141\u20135149.","journal-title":"Blood"},{"key":"BFleu2011152_CR25","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O\u2019Brien S et al. National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990\u20134997.","journal-title":"Blood"},{"key":"BFleu2011152_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/1097-0142(20000915)89:6<1259::AID-CNCR10>3.0.CO;2-G","volume":"89","author":"L Trentin","year":"2000","unstructured":"Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C et al. B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation. Cancer 2000; 89: 1259\u20131268.","journal-title":"Cancer"},{"key":"BFleu2011152_CR27","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.157.5.1854","volume":"157","author":"A Cerutti","year":"1996","unstructured":"Cerutti A, Trentin L, Zambello R, Sancetta R, Milani A, Tassinari C et al. The CD5\/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J Immunol 1996; 157: 1854\u20131862.","journal-title":"J Immunol"},{"key":"BFleu2011152_CR28","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1038\/sj.onc.1210519","volume":"26","author":"M Ticchioni","year":"2007","unstructured":"Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 2007; 26: 7081\u20137091.","journal-title":"Oncogene"},{"key":"BFleu2011152_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1083\/jcb.152.2.325","volume":"152","author":"H Keilhack","year":"2001","unstructured":"Keilhack H, M\u00fcller M, B\u00f6hmer SA, Frank C, Weidner KM, Birchmeier W et al. Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J Cell Biol 2001; 152: 325\u2013334.","journal-title":"J Cell Biol"},{"key":"BFleu2011152_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj20021535","volume":"371","author":"J Bain","year":"2003","unstructured":"Bain J, McLauchlan H, Elliott M, Cohen P . The specificities of protein kinase inhibitors: an update. Biochem J 2003; 371: 199\u2013204.","journal-title":"Biochem J"},{"key":"BFleu2011152_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","volume":"228","author":"U Lorenz","year":"2009","unstructured":"Lorenz U . SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev 2009; 228: 342\u2013359.","journal-title":"Immunol Rev"},{"key":"BFleu2011152_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(03)00400-1","volume":"306","author":"C Wu","year":"2003","unstructured":"Wu C, Sun M, Liu L, Zhou GW . The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 2003; 306: 1\u201312.","journal-title":"Gene"},{"key":"BFleu2011152_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06891.x","volume":"140","author":"ML Gabelloni","year":"2008","unstructured":"Gabelloni ML, Borge M, Galletti J, Ca\u00f1ones C, Calotti PF, Bezares RF et al. SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression. Br J Haematol 2008; 140: 117\u2013119.","journal-title":"Br J Haematol"},{"key":"BFleu2011152_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1139\/y06-012","volume":"84","author":"PD Simoncic","year":"2006","unstructured":"Simoncic PD, McGlade CJ, Tremblay ML . PTP1B and TC-PTP: novel roles in immune-cell signaling. Can J Physiol Pharmacol 2006; 84: 667\u2013675.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFleu2011152_CR35","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3319::AID-IMMU3319>3.0.CO;2-9","volume":"29","author":"G Sen","year":"1999","unstructured":"Sen G, Bikah G, Venkataraman C, Bondada S . Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol 1999; 29: 3319\u20133328.","journal-title":"Eur J Immunol"},{"key":"BFleu2011152_CR36","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.169.4.1735","volume":"169","author":"MJ Chumley","year":"2002","unstructured":"Chumley MJ, Dal Porto JM, Cambier JC . The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J Immunol 2002; 169: 1735\u20131743.","journal-title":"J Immunol"},{"key":"BFleu2011152_CR37","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.4049\/jimmunol.179.7.4335","volume":"179","author":"H Gary-Gouy","year":"2007","unstructured":"Gary-Gouy H, Sainz-Perez A, Marteau JB, Marfaing-Koka A, Delic J, Merle-Beral H et al. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. J Immunol 2007; 179: 4335\u20134344.","journal-title":"J Immunol"},{"key":"BFleu2011152_CR38","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cellsig.2005.05.016","volume":"17","author":"AW Poole","year":"2005","unstructured":"Poole AW, Jones ML . A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 2005; 17: 1323\u20131332.","journal-title":"Cell Signal"},{"key":"BFleu2011152_CR39","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/S0960-894X(02)00681-9","volume":"12","author":"G Arabaci","year":"2002","unstructured":"Arabaci G, Yi T, Fu H, Porter ME, Beebe KD, Pei D . alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-activity relationship. Bioorg Med Chem Lett 2002; 12: 3047\u20133050.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFleu2011152_CR40","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/onc.2009.179","volume":"28","author":"AD Baudot","year":"2009","unstructured":"Baudot AD, Jeandel PY, Mouska X, Maurer U, Tartare-Deckert S, Raynaud SD et al. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene 2009; 28: 3261\u20133273.","journal-title":"Oncogene"},{"key":"BFleu2011152_CR41","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1128\/MCB.20.5.1678-1691.2000","volume":"20","author":"M L\u00f3pez-Lago","year":"2000","unstructured":"L\u00f3pez-Lago M, Lee H, Cruz C, Movilla N, Bustelo XR . Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol Cell Biol 2000; 20: 1678\u20131691.","journal-title":"Mol Cell Biol"},{"key":"BFleu2011152_CR42","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.febslet.2010.05.061","volume":"584","author":"LW Thomas","year":"2010","unstructured":"Thomas LW, Lam C, Edwards SW . Mcl-1; the molecular regulation of protein function. FEBS Lett 2010; 584: 2981\u20132989.","journal-title":"FEBS Lett"},{"key":"BFleu2011152_CR43","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","volume":"66","author":"C Akgul","year":"2009","unstructured":"Akgul C . Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 2009; 66: 1326\u20131336.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu2011152_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.coi.2005.04.003","volume":"17","author":"VL Tybulewicz","year":"2005","unstructured":"Tybulewicz VL . Vav-family proteins in T-cell signalling. Curr Opin Immunol 2005; 17: 267\u2013274.","journal-title":"Curr Opin Immunol"},{"key":"BFleu2011152_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.immuni.2008.09.009","volume":"29","author":"WM Yokoyama","year":"2008","unstructured":"Yokoyama WM . Inhibitory receptors signal activation. Immunity 2008; 29: 515\u2013517.","journal-title":"Immunity"},{"key":"BFleu2011152_CR46","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.cdd.4402282","volume":"15","author":"G Koncz","year":"2008","unstructured":"Koncz G, Kerekes K, Chakrabandhu K, Hueber AO . Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase cells spend their life cycle is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling. Cell Death Differ 2008; 15: 494\u2013503.","journal-title":"Cell Death Differ"},{"key":"BFleu2011152_CR47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219\u2013234.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T23:27:45Z","timestamp":1712532465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFleu2011152"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.152","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]},"assertion":[{"value":"29 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}